+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

C-MET Non-Small Cell Lung Cancer (c-MET+ NSCLC) - Pipeline Insight, 2025 - Product Thumbnail Image

C-MET Non-Small Cell Lung Cancer (c-MET+ NSCLC) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Malignant Pleural Mesothelioma- Pipeline Insight, 2025 - Product Thumbnail Image

Malignant Pleural Mesothelioma- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Sezary Syndrome - Pipeline Insghts, 2025 - Product Thumbnail Image

Sezary Syndrome - Pipeline Insghts, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
CXCR4 Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

CXCR4 Receptor Antagonists - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Minimal Residual Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Minimal Residual Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
FTase (Farnesyltransferase) Inhibitor- Pipeline Insight, 2025 - Product Thumbnail Image

FTase (Farnesyltransferase) Inhibitor- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Hodgkin's Lymphoma- Pipeline Insight, 2025 - Product Thumbnail Image

Hodgkin's Lymphoma- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Extensive-Stage Small Cell Lung Cancer (ESCLC) - Pipeline Insight, 2025 - Product Thumbnail Image

Extensive-Stage Small Cell Lung Cancer (ESCLC) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Anti-PD-1 / Anti-PD-L1 Refractory Solid Tumors - Pipeline Insight, 2025 - Product Thumbnail Image

Anti-PD-1 / Anti-PD-L1 Refractory Solid Tumors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Acute Lymphoblastic Leukemia (ALL) - Pipeline Insight, 2025 - Product Thumbnail Image

Acute Lymphoblastic Leukemia (ALL) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Acute Myelogenous Leukemia (AML) - Pipeline Insight, 2025 - Product Thumbnail Image

Acute Myelogenous Leukemia (AML) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
chemotherapy-induced Bone Marrow Toxicities - Pipeline Insight, 2025 - Product Thumbnail Image

chemotherapy-induced Bone Marrow Toxicities - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
HPV-induced Cutaneous Tumors - Pipeline Insight, 2025 - Product Thumbnail Image

HPV-induced Cutaneous Tumors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Gliosarcoma - Pipeline Insight, 2025 - Product Thumbnail Image

Gliosarcoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
From
Metastatic Head And Neck Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Metastatic Head And Neck Cancer - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Undifferentiated Pleomorphic Sarcoma (UPS) - Pipeline Insight, 2025 - Product Thumbnail Image

Undifferentiated Pleomorphic Sarcoma (UPS) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more